Pathway and rights assessment
Clarify the proposed generic route, available data, permissions or reliance position and key program dependencies.
Technical equivalence and generic pesticide registration
A Canadian pathway for
generic market entry.
Registration strategy for generic and off-patent pesticide products, alternate technical sources and additional manufacturing sites entering Canada.
Same active ingredient does not mean same file
Equivalence is a conclusion
built from chemistry and evidence.
Differences in starting materials, reaction conditions, purification, equipment or manufacturing site can change the impurity profile and the data needed to characterize a technical source. The associated end-use product must also connect back to an acceptable source and supportable formulation.
We assess those relationships before the registration program is fixed, helping manufacturers understand what can be leveraged and what must be demonstrated independently.
Where we add value
Connect the source, data and
market-entry strategy.
Technical source evaluation
Review manufacturing process, starting materials, impurity profile, specifications, methods and representative batch data.
Alternate site strategy
Compare manufacturing sites and define the evidence needed to support an additional or changed source.
End-use product alignment
Connect the technical source to formulation composition, product chemistry, proposed uses and Canadian label.
Registration program
Translate the findings into a prioritized plan for data, rationales, dossier preparation and submission.
A focused engagement
Assess feasibility before
committing the portfolio.
Work can begin with one technical source or product and expand only after the Canadian path and major evidence risks are understood.
- 01Chinese and Indian technical manufacturers
- 02International generic pesticide formulators
- 03Alternate technical sources and manufacturing sites
- 04Off-patent active ingredient portfolios
- 05Companies comparing Canadian market-entry options
A generic registration plan grounded
in the actual source.
You receive a clear position on the proposed technical source, the evidence that can support it and the remaining work required for the Canadian application.
This allows commercial decisions to reflect regulatory reality before substantial testing, dossier or market-entry costs are committed.
Start with the file in front of you
Evaluating a generic product
for Canada?
Send the active ingredient, manufacturing-site information, intended end-use products and an overview of the available data package.
Discuss your project info@agrochemconsulting.com